BioNexus KC on LinkedIn: Kansas City is shedding its "flyover country" label and rebranding itself… (2024)

Seroba., a beacon of innovation in Dublin's life sciences scene, has triumphantly closed its Fund IV at a staggering €123M! 🌟💼 With a strategic eye on early-stage life sciences ventures, Seroba is set to revolutionise patient care by targeting up to 12 investments, already making waves with five promising companies. 🚀From the heart of Western Europe to select ventures in North America, this fund is not just an investment; it's a commitment to biotech breakthroughs and medical advancements. 🧬💉 With the backing of heavyweight investors and a keen focus on unmet medical needs, Seroba stands at the forefront of transforming patient treatment while offering a lucrative avenue for investors.Cheers to Seroba. for leading the charge in nurturing the next generation of life sciences innovations, proving once again that when it comes to improving human health, Ireland is on the cutting edge. 🇮🇪💚#LifeSciences #VentureCapital #HanleyAutomation

7

🚀 How do we gear up our organisation to commercialise and scale, without losing our innovative core? Today, in the third module of our life science scaleup program #10xHealth, our expert Anna Brattström from Lund University School of Economics and Management guided our 10xHealth companies through frameworks and tools relating to organising people, processes and organisational structures that are foundational for growth, managing the tension between explorative and exploitative phases of a company’s journey, as well as the shift from a focus on science to a focus on business.📈 The #10xHealth program is targeted towards life science companies with the ambition to grow and scale. It is jointly developed bySmiLe Venture HubandMedicon Villageand co-financed by theEuropean Regional Development Fund.🌟 Companies participating in the 2024 pilot include: Paindrainer AB,Iconovo AB,Neola Medical,Uman Sense,Cyxone,NanoEcho AB 📧 If you're curious to find out more, feel free to reach out toChristine Dahlman JacobsenorSarah Lidé.#lifescience #scalingup

55

🚀 **Exciting News from the #HPI_Entrepreneurship_Ecosystem!** 🌟 At HPI SEED, we're proud to announce the successful seed funding round of our latest spin-off, Seqstant GmbH. An impressive €1.8 million has been raised to advance the revolution in disease detection.Seqstant stands at the forefront of pathogen diagnostics. Their goal? To revolutionize medical diagnostics and improve patient care worldwide. 🧬 Founded at Hasso Plattner Institute as a spin-off and supported by HPI School of Entrepreneurship, Seqstant GmbH has developed a groundbreaking software called #LiveGene, capable of identifying pathogens with just a single click. This marks a turning point in treating severe infections by drastically reducing diagnosis times. 💡 The funding round is heavily supported by strong partners such as Brandenburg Kapital GmbH , Impact Investments, Venture League SB21 and of course, us at HPI SEED. 🏥 In a world increasingly challenged by new pathogens, acting quickly and precisely is crucial. Seqstant is a shining example of how #digital_innovation from the #HPI_Ecosystem can make a significant contribution to global health and safety. 🔍 With CE certification in sight and the continuous development of their technology, Seqstant is well on its way to transforming pathogen diagnostics and relieving the healthcare system. 🌍 We're thrilled to be part of this journey and look forward to supporting Seqstant's path to improving global healthcare. Henri Knobloch Bernhard Renard Moritz Matthey, Ph.D. Robin Alexander Staszek Dr. Jens Schmidt-Sceery Maximilian Mense Michael Mansfeld Anna Schnekker Franz Breu Annalena Lorson David Hahn Gregor von Dulong Rebecca Lepadus Clara Petter Lothar H. Wieler Hasso Plattner Foundation Leon Stebe #HPISEED #Innovation #HealthTech #StartUp #Investment

96

5 Comments

When you think about impact, what do you think of? Here at Medical Alley, one of the ways we measure our impact is through the health of the start up ecosystem. You can read more about how the ecosystem is growing and thriving through our Q3 venture report. Here are some of the highlights: - Despite market uncertainty, Medical Alley companies are set to secure the third-highest venture dollars since 2012. ⭐ - Medical Alley has outperformed major startup hubs, ranking third in U.S. venture capital per capita, trailing only California and Massachusetts. 🥉 - In Q3/2023, VC activity slowed, but there's an uptick in public market transactions (6) and M&A transactions (9). 📈 - Medical Alley companies achieved a milestone, securing nearly $22 million in SBIR/STTR funding, the highest since 2012. 💰 To learn more, you can download the venture report below: https://lnkd.in/gpbwsnEA#MedicalAlley #startup #venturecapital #healthcare #medicaldevice #biotech #innovationhub

8

We will be the only cannabinoid development company presenting at this event in London in November. Whenever I talk to potential investors about the size of the chronic pain market in the UK alone, and that cannabinoids are looking to be a very effective treatment for many pain conditions, people really stop and think. For so long cannabinoids have been about cannabis. That is now fast changing. Non psychoactive cannabinoids (especially CBD) have powerful anti inflammatory and analgesic effects. Many of the chronic pain conditions that impact the lives of millions of people to the extent they cannot work and cannot live their lives, have a large component of inflammation. CBD is being shown to be a very effective anti inflammatory treatment and it is safe. We've got detailed work to do to get the marketing authorisations and licences for cannabidiol based medicines but the lack of negative side effects is a big plus and makes the job much more straightforward than it otherwise would be. I reckon 'watch this space'. It is happening quickly, the unmet need is massive. I look forward to speaking at this event and meeting lots of potential investors! #capitalmarkets #equity #equityinvestment #equityinvesting #stockstowatch #stockstobuy

4

Verge Healthtech Fund is gearing up for three dynamic panel discussions at DTX ASIA 2023 tomorrow! First, head to the "Keynote Panel Discussion: Why Bring DTx to Asia?" on the morning of Nov 29. Listen to our Managing Partner, Scarlett Chen 陈思佳, and her co-panelists delve into success factors for digital therapeutics and its adoption in Asia, accessibility in low-resource settings, and integration with other health tools. 🌏Then in the afternoon, join our co-founder and Managing Partner, Joseph Mocanu, for the “A One Stop Shop on What A Digital Health Investor Seeks in a DTx Company" panel, where he and his co-panelists will explore the landscape of DTx investments, how they balance profitability with impact, and how to foster successful collaborations between DTx companies and investors. 🤝The following morning on Nov 30, catch our co-founder and General Partner, Ed Deng, appearing in the “Panel Discussion: Identifying the Gaps in DTx: What is the Industry Missing?” Ed will be representing his startup, Health2Sync 智抗糖, a comprehensive health management platform helping chronic disease patients improve their health conditions with personalized digital therapeutics.🩸Whether you're a startup on a mission to solve global health challenges through digital therapeutics, or a fellow investor of impactful healthtech startups, we invite you to connect. We’ll be at the summit until Nov 30. 👥#dtx #dtxasia #digitalhealth #digitaltherapeutics

45

1 Comment

Great "Always Forward" insights from Joe Urban truly a CEO that exemplifies Transformational Leadership. By definition, Transformational Leadership is, the ability of leaders tomotivateandinspireemployees and effectpositive changesin groups. Effective transformational leaders areemotionally intelligent, energetic and passionate. Those who know Joe know he embodies EQ with energy that is off the charts!

29

3 Comments

At the upcoming 10th Annual HealthTech Investment Forum in Switzerland (Sep 19), we will deeply explore the 'Revolution in Precision Medicine: Investing in Big Data and AI.' This journey isn't solely about technology or analytics; it's about the "in-between space" where "human intelligence" converges with "machine precision", all anchored by "high-quality, curated data", to redefine healthcare. Enabling personalized diagnosis and treatments, illuminating individual patient journeys, and optimizing therapeutic strategies is what we are all striving for in this space. To invest in this sector is to invest in a future where technology enhances our ability to heal and provide care and to push the limits of our understanding and achievements in healthcare. It's not merely a revolution but the evolution of care at its finest.

4

At the upcoming 10th Annual HealthTech Investment Forum in Switzerland (Sep 19), we will deeply explore the 'Revolution in Precision Medicine: Investing in Big Data and AI.' This journey isn't solely about technology or analytics; it's about the "in-between space" where "human intelligence" converges with "machine precision", all anchored by "high-quality, curated data" to redefine healthcare. Enabling personalized diagnosis and treatments, illuminating individual patient journeys, and optimizing therapeutic strategies is what we are all striving for in this space. To invest in this sector is to invest in a future where technology enhances our ability to heal, provide care, and to push the limits of our understanding and achievements in healthcare. It's not merely a revolution but the evolution of health and care at their finest. Join us to learn more!

39

6 Comments

Exciting news! Renowned investor Peter Thiel has just invested in a UK healthtech startup that aims to revolutionize the process of clinical trials. 🚀Clinical trials often present significant challenges when it comes to bringing new treatments and drugs to market efficiently. However, Lindus Health, the company receiving Thiel's investment, has developed a groundbreaking solution. They've created a single, all-encompassing platform that oversees and streamlines every stage of the trial process. By doing so, Lindus Health aims to accelerate the pace of clinical trials, ultimately benefiting patients and advancing medical innovations. 🏥Stay informed about this game-changing development and learn more about Lindus Health's platform by reading the blog post linked below:[Speeding up clinical trials?](https://ift.tt/p6yeiwl)Don't miss out on this intriguing story and the potential it holds for the future of medical research. ✨#clinicaltrials #healthtech #medicalresearch